Qiagen NV Ownership
| QGEN Stock | USD 42.33 0.24 0.57% |
Shares in Circulation | First Issued 1996-03-31 | Previous Quarter 222 M | Current Value 224 M | Avarage Shares Outstanding 188.5 M | Quarterly Volatility 48.5 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Qiagen |
Qiagen Stock Ownership Analysis
About 88.0% of the company shares are owned by institutional investors. The book value of Qiagen NV was at this time reported as 15.88. The company has Price/Earnings To Growth (PEG) ratio of 0.97. Qiagen NV last dividend was issued on the 30th of January 2024. The entity had 962:1000 split on the 25th of January 2017. QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company was founded in 1986 and is headquartered in Venlo, the Netherlands. Qiagen NV operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 6200 people. To find out more about Qiagen NV contact Thierry Bernard at 31 77 355 6600 or learn more at https://www.qiagen.com.Besides selling stocks to institutional investors, Qiagen NV also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Qiagen NV's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Qiagen NV's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Qiagen NV Quarterly Liabilities And Stockholders Equity |
|
Roughly 2.0% of Qiagen NV are currently held by insiders. Unlike Qiagen NV's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Qiagen NV's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Qiagen NV's insider trades
Qiagen Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Qiagen NV is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Qiagen NV backward and forwards among themselves. Qiagen NV's institutional investor refers to the entity that pools money to purchase Qiagen NV's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dekabank Deutsche Girozentrale | 2024-06-30 | 3.2 M | Millennium Management Llc | 2024-06-30 | 3 M | Victory Capital Management Inc. | 2024-09-30 | 2.6 M | Bnp Paribas Arbitrage, Sa | 2024-06-30 | 2.5 M | Capital Research & Mgmt Co - Division 3 | 2024-09-30 | 2.4 M | State Street Corp | 2024-06-30 | 2.3 M | Legal & General Group Plc | 2024-06-30 | 2.2 M | Citadel Advisors Llc | 2024-06-30 | 2.1 M | Deutsche Bank Ag | 2024-06-30 | 2.1 M | Massachusetts Financial Services Company | 2024-09-30 | 23.1 M | Wellington Management Company Llp | 2024-06-30 | 12 M |
Qiagen NV Outstanding Bonds
Qiagen NV issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Qiagen NV uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Qiagen bonds can be classified according to their maturity, which is the date when Qiagen NV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Qiagen NV Corporate Filings
6K | 8th of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
13A | 7th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
| 31st of May 2024 Other Reports | ViewVerify | |
| 30th of May 2024 Other Reports | ViewVerify |
Pair Trading with Qiagen NV
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Qiagen NV position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qiagen NV will appreciate offsetting losses from the drop in the long position's value.Moving together with Qiagen Stock
| 0.64 | A | Agilent Technologies Earnings Call This Week | PairCorr |
| 0.77 | ME | 23Andme Holding | PairCorr |
| 0.72 | VALN | Valneva SE ADR Downward Rally | PairCorr |
Moving against Qiagen Stock
| 0.76 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.75 | BMY | Bristol Myers Squibb | PairCorr |
| 0.57 | EXEL | Exelixis | PairCorr |
| 0.54 | FLGC | Flora Growth Corp | PairCorr |
| 0.46 | KTTAW | Pasithea Therapeutics | PairCorr |
The ability to find closely correlated positions to Qiagen NV could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Qiagen NV when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Qiagen NV - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Qiagen NV to buy it.
The correlation of Qiagen NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qiagen NV moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qiagen NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Qiagen NV can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qiagen NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qiagen NV. If investors know Qiagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qiagen NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.255 | Earnings Share 0.45 | Revenue Per Share 8.841 | Quarterly Revenue Growth 0.055 | Return On Assets 0.0484 |
The market value of Qiagen NV is measured differently than its book value, which is the value of Qiagen that is recorded on the company's balance sheet. Investors also form their own opinion of Qiagen NV's value that differs from its market value or its book value, called intrinsic value, which is Qiagen NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qiagen NV's market value can be influenced by many factors that don't directly affect Qiagen NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Qiagen NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Qiagen NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qiagen NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.